Still time to register for the Swedish IBD Updates - only 7 weeks away! Great agenda for clinicians, educators and trainees with interest in #IBD . Topics such as treatment optimization, neoplasia surveillance, combo advanced therapy. C/o the faculty roster swedishibd.com

Top feedback from IBD patients who took part in drug trials was reduce burden of questionnaires, colonoscopy, placebo, allow multidrug exposure and disease subtypes. Overall very positive experience of participation. Regulators and sponsors please pay attention!

We are well into the Treat to Target era in IBD . So many practical questions remain . Please join me , and the one and only Father of STRIDE Laurent Peyrin-Biroulet to have your practical questions addressed

Excited to announce our 2nd annual IBD Masterclass, which will be held Fri, May 17 in DC, the day before DDW. Please consider🚗✈️into town a day earlier for CME from our 🤩 faculty, and networking! Reception to follow, & trainees free! NM Gastroenterology & GI Surgery Register: medstar.cloud-cme.com/course/courseo…

This 👇 also puts a 'surgical hole' in the theory about the superiority of Kono-S. Follow Stefan Holubar MD MS for more surgical news and pertinent commentaries on #IBD #ECCO2024

Summary on #IBD issues in #pregnancy by Uma Mahadevan. This is a must view! GUILD Conference

Music to your ears: the #PIANO #IBD Queen, Dr Mahadevan Uma Mahadevan, reviewing #IBD management in pregnancy GUILD Conference

Very nice summary on vaccines in #IBD by Dr Gil Melmed Gil Melmed GUILD Conference

Things that can ⬆️ IBD onset and flares
✅Longterm NSAIDS
✅antibiotics
✅Hormonal therapy
✅ultra processed foods

⁦Fernando Velayos MD MPH⁩ ⁦David T. Rubin, MD⁩ ⁦GUILD Conference⁩

More answers on the stress & #UC colitis flares by the UCLA Health group: perceived stress associated with increased symptoms but perhaps also increased #IBD activity - cause & effect relationship still unclear David T. Rubin, MD Fernando Velayos MD MPH GUILD Conference

An urgent matter: don't forget to ask about #urgency in patients with UC #colitis , one of the most debilitating symptoms in patients with #IBD and a major determinant of quality of life - important treatment target David T. Rubin, MD and Fernando Velayos MD MPH GUILD Conference

The Russian Embassy in Lisbon, Portugal tonight.

The text is of Navalny’s famous message from beyond the grave:

“Don’t give up!”

New and exciting data with VDZ for postoperative prevention in #crohnsdisease from the REPREVIO trial reported by Miguel Regueiro. How does this 'compare' with IFX data? Excellent info to review w our patients GUILD Conference

#IBD guru Miguel Regueiro given a state of the art talk on postoperative management in #crohnsdisease GUILD Conference